%PDF-1.4
%
89 0 obj
<>
endobj
86 0 obj
<>
endobj
155 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-02-06T10:08:41Z
2024-03-28T01:20-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T01:20-07:00
application/pdf
Heather
2003-825.marchsupl.69
uuid:b1f4386d-1dd1-11b2-0a00-ae0927bd7700
uuid:b1f4386f-1dd1-11b2-0a00-900000000000
endstream
endobj
75 0 obj
<>
endobj
76 0 obj
<>
endobj
90 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 57 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 59 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 61 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 63 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 65 0 R/Type/Page>>
endobj
38 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 67 0 R/Type/Page>>
endobj
41 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 69 0 R/Type/Page>>
endobj
181 0 obj
[186 0 R]
endobj
182 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.8 g
/T1_0 18 Tf
0.6114 0.7912 -0.7912 0.6114 35.383 35.2215 Tm
(Personal, non-commercial use only. The Journal of Rheumatology. Copyrigh\
t \251 2004. All rights reserved.)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
0 0 0 1 K
/GS1 gs
54 54 m
558 54 l
S
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 354.2144 35.9844 Tm
[(The Journal of Rheumatology 2004, V)111 (olume 31, Supplement 69)]TJ
0 Tc 0 Tw -37.5268 -0.0313 Td
(54)Tj
ET
0 0 0 0 k
/GS0 gs
109.25 59.09 396.47 -10.83 re
f*
0.5 w
109.25 59.09 396.47 -10.83 re
S
BT
0 0 0 1 k
/GS1 gs
/T1_2 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 61 714.5293 Tm
[(5.)-875 (Y)100 (oung )55 (A, )18 (W)40 (ilkinson P)111 (, )18 (T)70 (alamo J, et al. Socio-economic factors in)]TJ
1.675 -1.25 Td
(the presentation and outcome of early rheumatoid arthritis. Lessons)Tj
0 -1.25 TD
[(for the health service? )55 (Ann Rheum Dis 2000;59:794-99.)]TJ
-1.675 -1.25 Td
[(6.)-875 (Jacoby RK, Jayson MIV)129 (, Cosh JA. Onset, early stages, and )]TJ
1.675 -1.25 Td
(prognosis of rheumatoid arthritis: a clinical study of 100 patients)Tj
T*
[(with 1)37 (1 year follow up. BMJ 1973;2:96-100.)]TJ
-1.675 -1.25 Td
[(7.)-875 (Brooks )55 (A, Corbett M. Radiographic changes in early rheumatoid)]TJ
1.675 -1.25 Td
[(arthritis. )55 (Ann Rheum Dis 1977;36:71-3.)]TJ
-1.675 -1.25 Td
[(8.)-875 (Lawrence JS. Radiological classification. In: Kellgren JH, editor)55 (.)]TJ
1.675 -1.25 Td
(Rheumatism in populations. London: Heinmann; 1977.)Tj
-1.675 -1.25 Td
[(9.)-875 (Fex E, Jonsson K, Johnson U, Eberhardt K. Development of )]TJ
1.675 -1.25 Td
(radiographic damage during the first 5-6 yr of RA: a prospective)Tj
T*
(follow-up study of a Swedish cohort. Br J Rheumatol )Tj
0 Tc 0 Tw T*
[(1996;35;1)37 (106-15.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(10.)-875 (van der Heijde DMFM, van Leeuwen )55 (A, van Riel PLCM, et al.)]TJ
2.175 -1.25 Td
(Biannual radiographic assessments of hands and feet in a three-year)Tj
T*
(prospective followup of patients with early rheumatoid arthritis.)Tj
T*
(Arthritis Rheum 1992;35:26-33. )Tj
-2.1381 -1.25 Td
[(1)37 (1.)-875 (Sharp JT)74 (, )18 (W)80 (olfe F)80 (, Mitchell DM. )18 (The progression of erosion and)]TJ
2.1381 -1.25 Td
(joint space narrowing scores in rheumatoid arthritis during the first)Tj
T*
[(twenty-five years of disease. )55 (Arthritis Rheum 1991;34:660-7.)]TJ
-2.175 -1.25 Td
[(12.)-875 (van Zeben D, Hazes J, Zwinderman )55 (A, )18 (V)111 (anderbroucke J, Breedveld)]TJ
2.175 -1.25 Td
[(F)80 (. Factors predicting outcome of rheumatoid arthritis: results of a)]TJ
T*
[(follow up study)65 (. J Rheumatol 1993;20:1288-96.)]TJ
-2.175 -1.25 Td
[(13.)-875 (Larsen )55 (A, Dale K, Eek M. Radiographic evolution of rheumatoid)]TJ
2.175 -1.25 Td
[(arthritis and related conditions by standard reference films. )55 (Acta)]TJ
T*
(Radiol 1977;18:481-91.)Tj
-2.175 -1.25 Td
[(14.)-875 (Bukhari M, Harrison B, Lunt M, Scott DGI, Symmons DPM,)]TJ
2.175 -1.25 Td
[(Silman )55 (AJ. )18 (T)35 (ime to first occurrence of erosions in inflammatory)]TJ
T*
[(polyarthritis: results from a prospective community-based study)65 (.)]TJ
T*
(Arthritis Rheum 2001;44:1248-53.)Tj
-2.175 -1.25 Td
[(15.)-875 (W)80 (olfe F)80 (, Sharp JT)74 (. Radiographic outcome of recent-onset RA: a )]TJ
2.175 -1.25 Td
[(19-year study of radiographic progression. )55 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1998;41:1571-82.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(16.)-875 (Y)100 (oung )55 (A, Corbett M, )18 (W)40 (infield J, et al. )55 (A)-220 (prognostic index for)]TJ
2.175 -1.25 Td
(erosive changes in the hands, feet, and cervical spines in early)Tj
T*
(rheumatoid arthritis. Br J Rheumatol 1988;27:94-101.)Tj
-2.175 -1.25 Td
[(17.)-875 (van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, van\325)18 (t)]TJ
2.175 -1.25 Td
(Hof MA, van Rijswijk MH, van de Putte LBA. Prognostic factors)Tj
T*
(for radiographic damage and physical disability in early )Tj
T*
[(rheumatoid arthritis. )55 (A)-220 (prospective follow up study of 147 patients.)]TJ
T*
(Br J Rheumatol 1992;8:519-25.)Tj
0 Tc -2.175 -1.25 Td
[(18.)-875 (W)80 (eyand CM, Hicok KC, Conn D, Goronzy JJ. )18 (The influence of)]TJ
-0.00011 Tc 2.175 -1.25 Td
(HLA-DR beta 1 genes on disease severity in rheumatoid arthritis. )Tj
T*
(J Clin Invest 1995;95:2120-6.)Tj
30.825 55 Td
[(19.)-875 (Combe B, Dougados M, Goupile P)111 (, et al. Prognostic factors for)]TJ
2.175 -1.25 Td
[(radiographic damage in early rheumatoid arthritis. )55 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(2000;44:1736-43.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(20.)-875 (Mottonen )18 (T)74 (, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J,)]TJ
2.175 -1.25 Td
[(Hannonen P)111 (. Only high disease activity and positive rheumatoid)]TJ
T*
(factor indicate poor prognosis in patients with early rheumatoid)Tj
0 Tc T*
[(arthritis. )55 (Ann Rheum Dis 1998;57:533-9.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(21.)-875 (Belghomari H, Saraux )55 (A, )55 (Allain J, Guedes J, )37 (Y)100 (ouinou P)111 (, le Gof)18 (f P)111 (.)]TJ
2.175 -1.25 Td
(Risk factors for radiographic articular destruction of hands and)Tj
T*
(wrists in rheumatoid arthritis. J Rheumatol 1999;26:2534-8. )Tj
-2.175 -1.25 Td
[(22.)-875 (Harrison B, )18 (Thomson )18 (W)92 (, Symmons D, et al. )18 (The influence of )]TJ
2.175 -1.25 Td
(HLA-DRB1 alleles and rheumatoid factor on disease outcome in an)Tj
T*
(inception cohort of patients with early inflammatory arthritis.)Tj
T*
(Arthritis Rheum 1999;42:2174-83.)Tj
-2.175 -1.25 Td
[(23.)-875 (Arnett FC, Edworthy SM, Bloch DA, et al. )18 (The )55 (ARA)-220 (1987 revised)]TJ
2.175 -1.25 Td
[(criteria for classification of rheumatoid arthritis. )55 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1988;31:315-24.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(24.)-875 (Solymossy C, Dixey J, Utley M, et al. Larsen scoring of digitized)]TJ
2.175 -1.25 Td
[(X-ray images. Rheumatology Oxford 1999;38:1)37 (127-9.)]TJ
-2.175 -1.25 Td
[(25.)-875 (Joint working group of BSR and RCP)111 (. Guidelines and audit)]TJ
2.175 -1.25 Td
(measures for the specialist supervision of patients with rheumatoid)Tj
T*
(arthritis. J Roy Coll Phys Lond 1992;26:76-82.)Tj
-2.175 -1.25 Td
[(26.)-875 (T)35 (ugwell P)111 (, Boers M. Proceedings of OMERACT)-257 (conference on)]TJ
2.175 -1.25 Td
(outcome measures in rheumatoid arthritis in clinical trials. )Tj
0 Tc T*
(J Rheumatology 1993;20:528-30.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(27.)-875 (Ritchie DM, Boyle JA, McInnes JM, et al. Clinical studies with an)]TJ
2.175 -1.25 Td
(articular index for the assessment of joint tenderness in patients)Tj
T*
(with rheumatoid arthritis. Q J Med 1968;147:393-406.)Tj
-2.175 -1.25 Td
[(28.)-875 (Fries J, Spitz P)111 (, )37 (Y)100 (oung D. Dimensions of health outcomes: the)]TJ
2.175 -1.25 Td
[(Health )55 (Assessment Questionnaire, disability and pain scales. )]TJ
T*
(J Rheumatol 1982;9:789-93.)Tj
-2.175 -1.25 Td
[(29.)-875 (van der Heijde DMFM, van\325)18 (t Hof MA, van Riel PLCM, et al.)]TJ
2.175 -1.25 Td
(Judging disease activity in clinical practice in rheumatoid arthritis:)Tj
T*
[(first step in the development of a disease activity score. )55 (Ann)]TJ
0 Tc T*
(Rheum Dis 1990;49:916-20.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(30.)-875 (MacGregor )55 (A, Ollier )18 (W)92 (, )18 (Thomson )18 (W)92 (, Jawaheer D, Silman )55 (A. )]TJ
2.175 -1.25 Td
(HLA-DRB1* 0401/0404 genotype and RA: increased association in)Tj
T*
[(men, young age of onset, and disease severity)65 (. J Rheumatol)]TJ
0 Tc 0 Tw T*
(1995;22:1032-6.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(31.)-875 (Y)100 (oung )55 (A. Short term outcomes in recent onset rheumatoid arthritis.)]TJ
2.175 -1.25 Td
(Br J Rheumatol 1995;34 Suppl 2:79-86.)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
ET
/GS2 gs
BT
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
69 0 obj
<>stream
8;Z\7#u\Yp%+P;AW:)FihF!U7;C
8ZWR0ZGSJqMM$Wcd6Y_tQE&hM(6"%n1A&;+p^/M-!H?X-.5o=097:jT.^[[FRC,+0
@!&eQ7K;_C\pQ9Y.$qfblrIksg8[4DI7s,YRM_hqqH6cjPAK2WcnVY4%?9i"NBG<`
j+Dn.d-?M4@Sob[BdL!"iHFF;J>r7@a:8V@$"oLa-qu(*0A,,$ZLa;C5O$H3`ZB8K
?qc2#S$]gM&=d.fee"jEXu]+hG0Vck<\ftVMjB=Bj6i=9okT#d4GOOhWU]`q]52Q0
4:^^AF/<9HSeFnuXM,[D/ru\[&P?_Oc<7?!1]`ne3JX4n#f@-J.=MG5`.L!X8r>.D
2Jn=XaJ=DD`!UoBBaOdH&!??*MC/U7idDK];s%SZ(hZA]pAk>INl?>J+j?"?D>68IKuMol#YqJ,&uO
p,)h3YtDt~>
endstream
endobj
73 0 obj
[/Indexed/DeviceRGB 255 72 0 R]
endobj
72 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
128 0 obj
<>
endobj
92 0 obj
<>
endobj
96 0 obj
<>
endobj
113 0 obj
<>
endobj
160 0 obj
<>
endobj
95 0 obj
<>
endobj
104 0 obj
<>stream
H|TPSWM"BċpI+|Tݠ(R-DIH@@>Dފy#TtX֕:vg}lWlK99ߏc&B/^ۜw(cXjڽa7ackpsܔ[#79gkR\#'Wk΅KʪN!H.isqq]&Y/](u]zijƮzD*&:&UZQk%RGLtj: 9TʥZy"VI(UdBA*WE,UkJKثSF(ZBv&ϙl8Ƴ>uSb1,#012<$$ sMզHKs9ݜ'\}fϺnĬl`6}[bKޜ9j0l@%}'澣Rek[~ޏ64ښnNߋ,vRh
PӚۏ hj]o30y_*nn@= ̽dƨաa[kI*DBNX6QtB~ED$)EYKW|k&/(;R}Uw qX.xE;aOo/_(?.O)ԧЎhQ1_xB7@1TO^S#@":>K[|6Xt0hdЎC^h%< j=I94z_HyJ#/
>z
о-Gn4rDR$Z,C72<LQU͉E{JBjTVfUL8Ry"%M
\(^ċ=u*W*?{3!)